Clinical risk stratification and antibiotic management of NDM and OXA-48 carbapenemase-producing Enterobacteriaceae bloodstream infections in the UK

J Hosp Infect. 2019 May;102(1):95-97. doi: 10.1016/j.jhin.2019.01.023. Epub 2019 Feb 1.
No abstract available

MeSH terms

  • Aged
  • Anti-Bacterial Agents / administration & dosage
  • Carbapenem-Resistant Enterobacteriaceae / enzymology
  • Carbapenem-Resistant Enterobacteriaceae / isolation & purification*
  • Disease Management*
  • Drug Therapy, Combination / methods
  • Enterobacteriaceae Infections / diagnosis*
  • Enterobacteriaceae Infections / drug therapy*
  • Enterobacteriaceae Infections / mortality
  • Female
  • Humans
  • Male
  • Middle Aged
  • Sepsis / diagnosis*
  • Sepsis / drug therapy*
  • Sepsis / mortality
  • Survival Analysis
  • Treatment Outcome
  • United Kingdom
  • beta-Lactamases / analysis

Substances

  • Anti-Bacterial Agents
  • beta-Lactamases
  • beta-lactamase NDM-1
  • oxacillinase